| (210) | Number of the EPO application | 21153365 |
| (220) | Filing date of the EPO application | 2016.08.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 07/2026, 2026.02.11 |
| (110) | EPO patent number | 3865514 |
| (21) | Number of the application | e 2022 0348 |
| (71) | Name(s) of applicant(s), code of the country | Amgen Research (Munich) GmbH, DE; |
| (72) | Name(s) of inventor(s), code of the country | RAUM Tobias, DE;
KUFER Peter, DE;
PENDZIALEK Jochen, DE;
BLUEMEL Claudia, DE;
DAHLHOFF Christoph, DE;
HOFFMANN Patrick, DE;
LUTTERBUESE Ralf, DE;
NAHRWOLD Elisabeth, DE; |
| (73) | Name(s) of owner(s), code of the country | AMGEN Research (Munich) GmbH, DE; |
| (54) | Title of the invention | BISPECIFIC ANTIBODY BINDING DLL3 AND CD3 |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61K 39/395 (2006.01.01); A61P 35/00 (2006.01.01) |
| (52) | Cooperative Patent Classification | C07K 16/2809 (EP); C07K 16/2809 (EP); A61K 40/11 (EP); A61K 40/11 (EP); A61K 40/4225 (EP); A61K 40/4225 (EP); A61P 35/00 (EP); A61P 35/00 (EP); C07K 16/28 (EP); C07K 16/28 (EP); A61K 2239/31 (EP); A61K 2239/31 (EP); A61K 2239/38 (EP); A61K 2239/38 (EP); A61K 2239/55 (EP); A61K 2239/55 (EP); A61K 2239/57 (EP); A61K 2239/57 (EP); C07K 2317/31 (EP); C07K 2317/31 (EP); C07K 2317/33 (EP); C07K 2317/33 (EP); C07K 2317/622 (EP); C07K 2317/622 (EP); C07K 2317/73 (EP); C07K 2317/73 (EP); C07K 2317/76 (EP); C07K 2317/76 (EP); C07K 2317/77 (EP); C07K 2317/77 (EP); C07K 2317/92 (EP); C07K 2317/92 (EP); C07K 2317/94 (EP); C07K 2317/94 (EP) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2022.04.30 |
| (30) | Priority | 201562199930 P, 2015.07.31, US; 201662290896 P, 2016.02.03, US |